High plasma ApoA1 and TG/HDL-C ratio predict faster progression
Once-promising HDL-targeted therapy fails to show plaque regression
“Good cholesterol” component combats melanoma, lung cancer
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy